(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide Structure
CAS No.
1174130-61-0
Chemical Name:
(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide
Synonyms
CS-2732;LY2456302;Aticaprant;Aticaprant (CERC-501);Aticaprant,CERC-501,LY-2456302;CERC-501(LY-2456302,Aticaprant);LY2456302;LY 2456302;CERC501;CERC 501;Aticaprant CERC-501 JNJ-67953964 LY2456302;CERC 501,inhibit,LY2456302,Opioid Receptor,Aticaprant,Inhibitor,CERC501,LY 2456302;(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide
CBNumber:
CB12638536
Molecular Formula:
C26H27FN2O2
Molecular Weight:
418.5
MOL File:
1174130-61-0.mol
Modify Date:
2024/7/2 8:55:00

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide Properties

Boiling point 519.2±50.0 °C(Predicted)
Density 1.201±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 1 mg/ml; DMSO: 5 mg/ml; Ethanol: 3 mg/ml; PBS (pH 7.2): insol
form A solid
pka 15.61±0.50(Predicted)
color White to off-white

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
2 0

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide Preparation Products And Raw materials

Raw materials

Preparation Products

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide Suppliers

Global( 50)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ExSyn Corp +91-2240546474 +91-2240546474 Maharashtra, India 25 58 Inquiry
Jinan Carbotang Biotech Co.,Ltd. +8615866703830 China 7621 58 Inquiry
Accela ChemBio Inc. +1-858-6993322 United States 19479 58 Inquiry
BOC Sciences +1-631-485-4226 United States 19553 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry
InvivoChem +1-708-310-1919 +1-13798911105 United States 6393 58 Inquiry
Suzhou Laing Biotechnology Co.,Ltd +86-13004516015 +86-18149392822 China 778 58 Inquiry
Nanjing Doge Biomedical Technology Co., Ltd +86-25-58227606 +86-15305155328 China 4128 58 Inquiry
Hebei Miaoyin Technology Co.,Ltd +86-17367732028 +86-17367732028 China 3581 58 Inquiry
LEAPCHEM CO., LTD. +86-852-30606658 China 43348 58 Inquiry

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide Spectrum

(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide LY2456302 LY2456302;LY 2456302;CERC501;CERC 501 CS-2732 CERC-501(LY-2456302,Aticaprant) Aticaprant Benzamide, 4-[4-[[(2S)-2-(3,5-dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluoro- 4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide Aticaprant (CERC-501) CERC 501,inhibit,LY2456302,Opioid Receptor,Aticaprant,Inhibitor,CERC501,LY 2456302 Aticaprant,CERC-501,LY-2456302 Aticaprant CERC-501 JNJ-67953964 LY2456302 (S)-4-[4-[[2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide 1174130-61-0